TLC-518

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameTLC-518
Drug Alias NameSemaglutide Long-acting preparations (Taiwan Liposome)TLC-518TLC518
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Biosimilar
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsBody WeightMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Liposome Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Liposome Company Ltd
Inactive CompaniesN/A
Active IndicationsBody WeightMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A